Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have chaperone binding activity; protein kinase binding activity; and protein tyrosine phosphatase activity. Predicted to be involved in several processes, including mitotic cell cycle phase transition; positive regulation of cell cycle G2/M phase transition; and positive regulation of cholangiocyte proliferation. Localizes to cytoplasm and nucleus. Is expressed in several structures, including adrenal gland; central nervous system; gonad; gut; and thymus. Human ortholog(s) of this gene implicated in autosomal recessive polycystic kidney disease; cervical cancer; prostate cancer; and urinary bladder cancer. Orthologous to human CDC25A (cell division cycle 25A).